Latest News in Biostatistics

Dr. Tassos Kyriakides, PhD ‘99, assistant professor of biostatistics, received the Award for Excellence from the Association of Yale Alumni in Public Health (AYAPH).

Whether developing a new test for malaria, exposing health risks associated with climate change, or highlighting the impact of stigma on LGBTQ+ population well-being, Yale School of Public Health faculty advanced science in a variety of impactful ways over the past year.

In honor of National Cancer Research Month, Dr. Jeffrey Townsend shares why his research is focused on cancer.

Depending on where they live, older Americans can be at significantly higher risk for mortality and age-related disabilities, two new Yale studies find.

A new study by researchers at the Yale School of Public Health finds that broad genomic profiling, an emerging oncology tool that can help identify targeted therapies for cancer patients, remains widely underused—even among certain cancers for which the test is explicitly recommended.

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer, according to a new Yale study.

A sweeping new study led by researchers at the Yale School of Public Health reveals striking disparities in life expectancy across U.S. states and the District of Columbia over the past century. The study provides new insights into how public health policies, social conditions, and environmental factors appear to have fundamentally shaped Americans’ longevity based on where they live.

A long-acting monoclonal antibody prevents serious RSV illness in most infants. But timing matters to ensure maximum effectiveness.

Yale School of Public Health (YSPH) took center stage at a Yale symposium on April 5, 2025, when Dean Megan L. Ranney, MD, MPH, led a discussion with four distinguished Yale faculty members on the challenges and opportunities in higher education.